Reckitt Benckiser Group PLC (OTCMKTS:RBGLY – Get Free Report) shares gapped up before the market opened on Tuesday . The stock had previously closed at $14.87, but opened at $15.35. Reckitt Benckiser Group shares last traded at $15.39, with a volume of 40,022 shares trading hands.
Analysts Set New Price Targets
A number of analysts have recently issued reports on RBGLY shares. Royal Bank Of Canada reissued an “outperform” rating on shares of Reckitt Benckiser Group in a research note on Friday, July 25th. Sanford C. Bernstein raised shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research note on Thursday, June 5th. Three research analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Buy”.
View Our Latest Analysis on RBGLY
Reckitt Benckiser Group Stock Performance
Reckitt Benckiser Group Cuts Dividend
The firm also recently declared a dividend, which was paid on Thursday, September 25th. Stockholders of record on Monday, August 11th were paid a dividend of $0.2106 per share. The ex-dividend date was Friday, August 8th. This represents a dividend yield of 341.0%.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Recommended Stories
- Five stocks we like better than Reckitt Benckiser Group
- How to Invest in Blue Chip Stocks
- Apple Stock Positioned for Holiday Gains With iPhone 17 Boost
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Fundamentals Say Bet Against the Recent Adobe Downgrade
- 3 Healthcare Dividend Stocks to Buy
- AppLovin Stock Momentum Builds With $800+ Analyst Price Target
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.